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Summary
Rapid mining of large genomic and metagenomic data sets for modular polyketide
synthases, non-ribosomal peptide synthetases and hybrid polyketide synthase/non-riboso-
mal peptide synthetase biosynthetic gene clusters has been achieved using the generic
computer program packages ClustScan and CompGen. These program packages perform
the annotation with the hierarchical structuring into polypeptides, modules and domains,
as well as storage and graphical presentations of the data. This aims to achieve the most
accurate predictions of the activities and specificities of catalytically active domains that
can be made with present knowledge, leading to a prediction of the most likely chemical
structures produced by these enzymes. The program packages also allow generation of no-
vel clusters by homologous recombination of the annotated genes in silico. ClustScan and
CompGen were used to construct a custom database of known compounds (CSDB) and of
predicted entirely novel recombinant products (r-CSDB) that can be used for in silico scree-
ning with computer aided drug design technology. The use of these programs has been
exemplified by analysing genomic sequences from terrestrial prokaryotes and eukaryotic
microorganisms, a marine metagenomic data set and a newly discovered example of a
'shared metabolic pathway' in marine-microbial endosymbiosis.
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Introduction
It is well known that more than 50 % of drugs that
are in clinical use today belong to the polyketide or non-
-ribosomal peptide families of natural products. As well
as antibacterials, antifungals, antivirals and cytostatics, a
number of immunosuppressants, antihypertensives, anti-
diabetics, antimalarials and chlolesterol-lowering poly-
ketide and non-ribosomal peptide synthase-derived drugs
are in clinical use. Polyketide and non-ribosomal pep-
tide antiparasitics, coccidiostatics, animal growth pro-
moters and natural insecticides are also used in the food
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and agro-industries and should be added to this list of
useful biological activities (1–5). Polyketides and non-
-ribosomal peptides are, therefore, very important classes
of compounds which will continue to be sourced for nov-
el drug discovery. The year 2009 marked the eightieth
anniversary of the discovery of penicillin (6). In the inter-
vening years, pharmaceutical companies and academic
institutions had screened cultivable microorganisms from
different habitats for their natural products. Tens of thou-
sands of biologically active polyketides and non-riboso-
mal peptides with important pharmacological properties
have been discovered, but only 350 antimicrobials have
found their way to the market (7). Therefore, only 1 to 3
biologically active chemical entities per 10 000 described
have found clinical use. During the last 40 years or so,
the numbers of natural products reaching the market
sourced from cultivable microorganisms has declined
considerably. The major question now is: are there any
alternative strategies to exploit the chemical potential of
small-molecule natural products?
The answer might lie in the recent development of
rapid and inexpensive DNA sequencing technologies,
which have resulted in over 1050 sequenced bacterial
genomes, with more than 3000 additional genome se-
quencing projects in progress [NCBI Genome, May 2010
(8)]. Modular polyketide synthase (PKS) and non-ribo-
somal peptide synthethase (NRPS) gene clusters, which
can collectively be called Thiotemplate Modular Systems
(TMS), have been analyzed within about 250 bacterial
genomes. It has been shown that the bacteria whose
genomes are smaller than 4 Mb have only a few or no
TMS gene clusters. The number of gene clusters present
in a genome increases rapidly with the size of the
bacterial genome (9). Many actinomycetes, such as
Streptomyces species, have large genomes of around 8
Mb in size. All such species sequenced to date encode
from 20 to 40 gene clusters for the synthesis of second-
ary metabolites (10). For instance, the genome of Strep-
tomyces avermitilis contains gene clusters encoding three
well known polyketides: the antiparasitic avermectin and
the antibiotics oligomycin and filipin. In addition, there
is a Type III PKS (rpp) as well as eight PKS and eight
NRPS gene clusters with unknown biosynthetic products.
When the gene clusters encoded within the genomes of
Streptomyces coelicolor, Saccharopolyspora erythraea, Strepto-
myces griseus, Salinispora tropica, Salinispora arenicola and
Rhodococcus jostii are considered, there are almost 200
gene clusters for secondary metabolites within only seven
genomes of which almost 150 have unknown biosyn-
thetic products (10). To date hundreds of sequenced sec-
ondary metabolite gene clusters encoding unknown pro-
ducts have been deposited in public databases and their
number is growing exponentially. It can be expected that
with the development of 'next generation' sequencing
technology (11), more than 1000 actinomycete genomes
will be sequenced in the next year or two. If every se-
quenced genome contains about 20 secondary metabo-
lite gene clusters of unknown biosynthetic products,
more than 20 000 as yet unidentified chemical entities
can be expected. The majority of these gene clusters are
probably actively expressed. They have typical TMS gene,
module and domain organisation with no detectable re-
arrangements or mutations which would result in in-
active enzymes. It is reasonable to believe that there is,
therefore, a significant untapped chemical diversity in
these sequenced genomes and gene clusters. A major
problem of traditional screening is the reisolation of
known compounds (7). It is clear that a similar problem
will eventually arise with the data mining of genome
sequences. However, to date, most clusters detected in
genome sequences are novel in the sense of not having a
high degree of sequence similarity with known clusters.
The analysis tools provided by ClustScan provide enough
chemical information to detect close analogues of known
polyketides and peptides. As DNA sequencing is much
cheaper and less labour-intensive than chemical purifi-
cation and characterisation (11), the elimination of such
compounds at a DNA level makes this approach viable
even if increasing data makes the occurrence of known
structures common. At present, the data do not allow a
reliable estimate of the total chemical diversity that can
be found by a DNA sequencing approach.
Developments in metagenomics (12) have also opened
up new opportunities to access the genomes and, hence,
metabolic potential of the uncultivable majority of mi-
croorganisms. For example, in 2007 the J. Craig Venter
Institute (13) published the results of the Sorcerer II glob-
al ocean sampling expedition to evaluate the microbial
diversity in the world's oceans using molecular tools and
techniques originally developed to sequence the human
genome. Their data represent the largest metagenomic
data set ever released into the public domain, with al-
most 8 million sequencing reads, comprising over 6 bil-
lion base pairs of DNA. Bioinformatic tools are now need-
ed to rapidly mine such massive data set to hunt for
gene clusters encoding entirely novel compounds that
could be the source of information, which will aid the
development of the medicines of the future. This is
where we hope our approach will become important.
Here we describe the development of a novel ap-
proach for in silico drug design and discovery that links
DNA sequences encoding modular enzymes that synthe-
size polyketide and non-ribosomal peptide natural prod-
ucts of clinical importance to their in silico medicinal
chemistry. This is made possible because there is a direct
correlation between the DNA sequence of the gene clus-
ter and the chemical structure of the biosynthetic prod-
uct they encode. Therefore, polyketide and non-riboso-
mal peptide chemical structures can be predicted with a
relatively high probability from the gene cluster DNA
sequences.
Materials and Methods
Bacterial gene and genome (8) databases were down-
loaded from the FTP server at NCBI onto the Bioserv
server (14), which is the bioinformatics server of the
Faculty of Food Technology and Biotechnology, Univer-
sity of Zagreb, Croatia and used locally as the starting
point for the accession of sequenced polyketide and non-
-ribosomal peptide gene clusters. BLAST (15) searches of
the bacterial genes and genomes were done locally using
databases on the Bioserv. The bacterial polyketide and
non-ribosomal peptide domain sequences were accessed
from the PKSDB-NRPSDB and ASMPKS databases (16,
17).
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The generic computer program packages ClustScan
and CompGen (licensed by Novalis, Ltd, Zagreb, Croatia)
were used for gene cluster annotation and novel poly-
ketide structure generation, respectively (18,19). Coding
regions were identified using Glimmer (20) and Gene-
Mark (21). The DNA sequences were translated using
Transeq (22). Custom profile design and searching with
profiles used the HMMER suite of programs (23) and
the Pfam database (24).
A special data structure was developed to describe
modular clusters. It includes a hierarchical organisation
of the clusters into polypeptides, modules and domains
as well as information specifying the biosynthetic order
of the polypeptides and the specificity and functionality
of the domains. For structuring of the custom databases
CSDB (ClustScan DataBase) and r-CSDB (recombinant-
-ClustScan DataBase), which can be searched at the TMSS
(Thiotemplate Modular Systems Studies) web portal (25),
as well as for the development of the computer program
packages ClustScan and CompGen (18,19), the following
informatics tools and languages were used: Universal
Markup Language (UML, 26), BioSQL v. 1.29 (27), Perl
(28), Java (29) and JavaScript (30). Chemical structures of
the starter and extender building blocks were designed
as extended isomeric SMILES (Simplified Molecular In-
put Line Entry System, 31) using Jmol (32) and/or Chem-
Axon (33).
Results and Discussion
Two generic computer program packages named Clust-
Scan and CompGen (18,19) were developed. ClustScan and
CompGen are acronyms for 'Cluster Scanner and Comp-
ound Generator' and are written in Perl (28), Java (29)
and JavaScript (30). ClustScan and CompGen run on a
Linux server with a Java client on the user's computer
compatible with Windows, MacIntosh and Linux operat-
ing systems. The ClustScan program package lets users
perform rapid data mining (19). It allows convenient, rap-
id, semi-automatic annotation of modular biosynthetic
clusters with knowledge-based predictions of enzyme prop-
erties: domains, activities and domain specificities. The
main features of the ClustScan program package are
shown in Fig. 1. Namely, DNA sequences can be import-
ed from any file supported by ReadSeq (34); either from
the web or the user's hard disk. Once imported, the
DNA sequence is automatically translated into amino
acid sequence using Transeq (22). Genes can be localized
within the translated protein sequences by Glimmer (20)
or GeneMark (21). The domains of polyketide or non-ribo-
somal peptide gene clusters can then be identified with-
in these genes using the HMMER suite of programs (23)
with stringent or relaxed parameters, exploiting protein
profiles from the Pfam database (24) or customized pro-
files. The final annotation can be exported as EMBL, Gen-
Bank or XML file for use in other applications (18,19), or
for the upload to CSDB or r-CSDB databases (25).
The accuracy of prediction domain activity and spec-
ificity, and the speed and convenience of annotating
large DNA data sets make ClustScan a useful tool. The
accuracy of prediction was tested on a number of well-
-known gene clusters; e.g. the erythromycin gene cluster
(GenBank accession number AY771999) (Fig. 2). The
'Cluster' editor (Fig. 2a) and the 'Workspace' window
(Fig. 2b) show all three erythromycin genes together
with all their domains. The annotation of the cluster is
carried out using the 'Cluster' editor, which shows genes
of the cluster in a simple cartoon form, hence the term
semi-automatic. When a gene is selected, the domains
are shown. The 'Workspace' window shows the results
of the annotation in a tree format in which branches can
be opened up or collapsed. This is useful to obtain an
overview. However, the overall annotation of the erythro-
mycin biosynthetic genes can be best viewed in the
'Annotation' editor (Fig. 2c) where domains are assigned
to modules and modules to genes. For example, Clust-
Scan correctly predicted that inactive KR domain in mod-
ule 3 is responsible for S b-carbon stereochemistry. From
the annotated data, ClustScan can automatically predict
a structure of the predicted linear 6-deoxyerythronolide
(6dEB) polyketide-derived chain using building blocks
saved as isomeric SMILES (31) in a two- or three-dimen-
sional form (2-D or 3-D) suitable for further computer
processing. Based on the prediction of a linear polyke-
tide backbone, the program also automatically produces
a 2-D or 3-D cyclic structure of the erythromycin agly-
con (6-dEB). The ClustScan programme package is used
to upload the public database CSDB developed as a web
application using AJAX technology (Google Web Tool-
kit, 35), which can be searched at TMSS web portal (25).
The J. Craig Venter Institute metagenomic data set
(13) was also analyzed. This revealed a potential hybrid
PKS/NRPS gene cluster of about 50 kb in size. The
cluster begins by encoding a peptide loading domain,
followed by three putative PKS modules and seven pu-
tative NRPS modules, ending with an NRPS thioesterase
domain. When the location of the domains with respect
to the predicted polypeptides is examined, the cluster
appears to have been inactivated by several frameshifts.
However, because of the technical problems with meta-
genomic DNA samples, the quality of the sequence is
usually much lower than for genome projects. This makes
it likely that the cluster is indeed functional, and the
graphical overview provided by ClustScan makes correc-
tion for sequencing errors relatively easy. Based on this
analysis, it is suggested that there are three apparent
frameshifts and one false stop codon due to sequencing
errors. Thus, it seems likely that there are three genes
rather than the seven indicated by both GenMark and
Glimmer analysis. In the case of two of the putative poly-
ketide modules, no acyl transferase domains are recog-
nized, but there are unassigned regions in the putative
protein of appropriate sizes and locations for acyl trans-
ferase domains. Thus, the program allows rapid scan-
ning of metagenomic data sets and makes it easy to
identify potential sequencing errors and interesting fea-
tures of gene clusters. With the growing importance of
metagenomic data for drug discovery programs, Clust-
Scan helps to eliminate major bottlenecks in the analysis,
showing the speed and convenience of annotating large
DNA data sets (18,19). The current version of ClustScan
can be downloaded from the Bioserv (14) web site. Most
of the current metagenomic DNA sequences are in short
contigs (<10 kb), which makes detection of complete
modular biosynthetic clusters impossible. However, ra-
pid technical progress should result in future data sets
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with much larger contig sizes, which will reveal novel
clusters.
In 2007, Peter Leadlay's group at the University of
Cambridge published the DNA sequence of the Saccha-
ropolyspora erythraea genome (36), the producer of ery-
thromycin. The Streptomyces scabies genome was also
sequenced and is publicly available, although not yet
published (37). These genome sequences were used to
evaluate ClustScan regarding the speed and convenience
of annotating large DNA data sets (Fig. 3). TMS gene
clusters in both genomes were annotated in about three
hours by a person familiar with the ClustScan program
package. In principle, it would be possible to achieve the
same results by using individual tools such as BLAST
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Fig. 2. The 'Cluster' editor (a), the 'Workspace' window (b) and the 'Annotation' editor (c) are shown using the example of the
erythromycin gene cluster (modified from reference 21 with the permission of publisher)
Fig. 1. The main features of the ClustScan program package. The annotation editor window at the back shows the DNA sequence
with in silico translation in all six reading frames. The file menu allows import and export of data and the option to import DNA is
boxed. Clicking on this item gives a second menu which gives options for import of DNA sequence from different sources. The gen-
eral analysis tools to find domains (HMMER) or genes (GeneMark or Glimmer) are given in a further menu. When HMMER searches
are undertaken, the menu offers a choice of stringent or relaxed parameters. Once annotation has been successfully completed, an
annotated file in standard format can be exported using the option in the file menu (boxed)
(15), HMMER (23) and GenMark (21). The results could
then be combined with an extensive knowledge of the
literature about the activity and specificity of domains to
produce predictions of module specificity. These could be
combined with chemical expertise to produce a predict-
ed chemical structure of the product. This would take at
least three to four weeks, but probably much longer. It
would also require a much greater degree of bioinfor-
matic expertise and a much more detailed knowledge of
the literature than needed for using ClustScan. A further
serious problem that should not be underestimated is
that human analysis of such complex data will frequent-
ly lead to errors that are difficult to detect as the details
of each step of the analysis will usually not be docu-
mented. Therefore, use of the ClustScan program pack-
age should significantly increase the productivity of
scientists when faced with the annotation of complex
biosynthetic processes from large genome and meta-
genome data sets (18,19).
ClustScan is mainly designed for use with bacterial
sequences (18,19). However, the generic nature of the
ClustScan program package has also been tested for the
analysis of sequences from lower eukaryotes, where in-
tron prediction is often difficult. An example is provided
by the slime mould Dictyostelium discoideum, which was
found to encode 45 PKS genes, the largest number yet
described in a single organism (38). It was possible to
use local HMMER profiles for the predicted PKS do-
mains to effectively recognize segments of the domains
split by introns. When such an analysis is carried out, a
PKS gene displays a characteristic signature with parts
of the protein domains in the correct order, but with
gaps due to introns in between. The view in the 'Anno-
tation' editor window allows easy recognition of genes
and the coordinates of the domain segments help in de-
tecting the intron boundaries (Fig. 4). Although Clust-
Scan is mainly designed for the annotation of gene clust-
ers encoding modular biosynthetic enzymes (18,19), it
can also be used for annotating other genes by loading
appropriate HMMER protein profiles. For instance, we
have used seven profiles to find and annotate shikimic
acid pathway genes in a marine animal Nematostella vec-
tensis, challenging the traditional view that animals are
considered to lack this pathway as evidenced by their
dietary requirement for shikimate-derived aromatic amino
acids. Using ClustScan, these genes either had codon usage
that strongly implicates horizontal gene transfer from a
bacterial donor, or contained introns suggesting a dino-
flagellate ancestor (39).
In contrast, the major objective of CompGen (the de-
tails of which will be published elsewhere, but have been
discussed in reference 18) is structuring and mainte-
nance (i.e. updating as improved knowledge becomes
available) of the propriety custom database, r-CSDB
(25), of the entirely novel chemical entities generated by
in silico modelling of the homologous recombination be-
tween sequenced gene clusters. Prediction of the chem-
ical product of recombinants is more difficult for NRPS
clusters than for PKS clusters, but is also possible in many
cases. The r-CSDB was also developed as a web appli-
cation using AJAX technology (35) and can also be searched
at TMSS web portal (25). Like ClustScan, CompGen also
predicts the most likely chemical structures of the in sil-
ico generated recombinants. The future of CompGen will
be to produce structures that can be used for in silico
prediction of biological activity, for instance, modelling
the interaction with protein targets using computer aid-
ed drug design technology (40). In nature, homologous
recombination requires about 30 bp of identical sequence
called MEPS (Minimal Efficient Pairing Sequence), flanked
by around 200 bp of sequence sharing greater than 75 %
similarity (41,42). The CompGen recombination program
finds identity and similarity in two sequences and links
their coordinates to a custom database so that domains,
linkers and dockers involved in the recombination pro-
cess can be recognized. Why is Streptomyces a good
choice for generating recombinants? Streptomyces DNA
has a high G+C content and this introduces constraints
on codon usage. This results in longer stretches of se-
quence identity and similarity than for DNA sequence
pairs with a less extreme G+C content, which encode
homologous modules of PKS and NRPS clusters. Strepto-
myces have no mutSL genes which prevent recombina-
tion between sequences with mismatches (43). In addi-
tion, Streptomyces chromosomes and plasmids are often
linear; single crossovers would, thus, result in two linear
recombinant molecules rather than in a single fusion mole-
cule that would occur with circular parent molecules
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Fig. 3. The annotation of the TMS gene clusters in Saccharopoly-
spora erythraea and Streptomyces scabies genomes
(44,45). Circular molecules must undergo a double cross
over to generate two recombinant molecules and this
would be expected to be a much rarer event. However,
the recombination process in Streptomyces is not well
understood. Streptomyces do have recA genes for homo-
logous pairing, but seemingly do not have homologues
of recBCD or addAB genes (46,47). However, there are 4
conserved potential DNA helicases in the genomes of S.
coelicolor A3(2), S. avermitilis and Sacc. erythraea (10). It is
intriguing to speculate that one of these may encode an
enzyme with similar activities. Nevertheless, by using
parameters of 27 bp MEPS identity and over 75 % simi-
larity in the neighbouring 200 bp, 275 putative recom-
bination sites between 16 well described clusters were
obtained, which gives an average of 2–3 recombination
sites per cluster pair. Therefore, if 1000 gene clusters
were available, recombination between these cluster pairs
would generate 2–3 million recombinants. Preliminary
data indicate that 30–50 % of recombinants have a PKS
structure compatible with encoding a functional product
so that it should be theoretically possible to generate
approximately a million novel chemical entities.
As an example, two PKS gene clusters can be taken:
one encoding the 16-membered macrolide niddamycin
and the other encoding the 14-membered macrolide ery-
thromycin (GenBank accession numbers AF016585 and
AY771999). The niddamycin gene cluster contains five
genes encoding seven modules that incorporate eight
building blocks into the niddamycin aglycone. In con-
trast, the erythromycin gene cluster contains three genes
encoding six modules that incorporate seven building
blocks into the erythromycin aglycone. The computer
program for modelling in silico homologous recombina-
tion between these two gene clusters predicts 4 putative
recombination sites, i.e. eight novel recombinant gene
clusters. In one of them, the recombination occurs be-
tween the nidAIV and eryAII genes, which contain a
common EPS (Efficient Pairing Sequence) of 28 nucleo-
tides within 200 bp of over 75 % sequence similarity.
The recombination program recognizes the start and the
stop coordinates of the predicted EPS and localizes these
within the KS6 domain of nidAIV and the KS3 domain
of eryAII. Recombination would generate two novel gene
clusters, Rec-1 and Rec-2. The CompGen recombination
program can, from the activities and specificities of poly-
ketide domains and from the building blocks saved as
isomeric SMILES (31), predict the putative 12- and 18-
-membered linear chains and aglycones that could po-
tentially be produced by the resulting hybrid synthases.
A tool that helps the analysis of new gene clusters is
the PKSDB-NRPSDB database (16) (SEARCHPKS, 48),
which holds data on publically available polyketide and
peptide gene clusters including domain and module ar-
chitecture and the chemical structures of the gene clus-
ter products. It allows users to input protein sequences
to be used in BLAST searches (15) to identify domains
and to find the closest matching sequences in the data-
base. This allows prediction, for example, of whether an
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Fig. 4. The Dictyostelium discoideum gene pks29. The annotation editor window has been zoomed out to give an overview of the gene
so that the DNA and amino acid sequences are not shown; as all the gene is encoded by the lower strand, the viewing option has
been set for only the three reading frames on this strand. The HMMER hits to PKS domains are shown in the dark bars within the
reading frame. There are four hits to the ketosynthase (KS) domain (boxed). By right clicking on these hits, it is possible to obtain
the detail windows, which show coordinates of hits as well as the region of the profile, which is aligned with the hits. These data
show that the four hits correspond to successive regions of the profile without any gaps, which indicates that the KS domain is split
by three introns. The exon and intron coordinates can be deduced from the coordinates of the KS domains recognised by the local
profile
AT domain uses malonyl-CoA or methylmalonyl-CoA as
a substrate (i.e. whether a C2 or C3 unit is incorporated
into the polyketide). Another useful resource is the
ASMPKS database (17) with a tool MAPSI, which uses a
similar analysis methodology to SEARCHPKS, but inte-
grates it with a graphical display that shows the pres-
ence of domains in genes so that modules can be easily
recognized. It also allows display of a predicted linear
polyketide chain product for which the user has to select
starter and extender units from a list. However, the
stereochemistry of the product is not considered.
The company ECOPIA has also developed a soft-
ware tool, DecipherITTM (49), which helps annotation of
new gene clusters based on the comparison with a data-
base of known clusters. A slightly different tool is the
Biogenerator program (50) that allows construction of new
polyketides based on the known modules in silico. The
programs described above all depend on comparisons
with sequences in a database to analyze new gene clus-
ters. They are very suitable for analysing clusters closely
related to well characterized gene clusters. However, all
the programs mentioned above use predictions based on
similarity searches and do not predict domain activities/
specificities and stereochemistry. A similarity approach
using BLAST (15) suffers from the problems that the
weighing of each residue is independent of the position
and that insertion or deletion of residues is not handled
well. In contrast, the hidden Markov model (HMM)
approach used in the HMMER suite of programs (23)
deals with each amino acid position separately and,
thus, distinguishes between critical highly conserved
residues and less important positions. In addition, the
HMMs consider insertion and deletion states and assign
them probability. The hmmalign program of the HMMER
suite aligns sequences with respect to the HMM profile,
allowing accurate identification of particular residue
positions. Such HMM approaches were used to predict
substrate specificity of non-ribosomal peptide adenyla-
tion domains, which has been incorporated into a pro-
gram package called the NRPSpredictor (51).
We compared the performance of ClustScan (19) to
that of the SEARCHPKS and MAPSI prediction programs
implemented within PKSDB-NRPSDB and ASMPKS data-
bases (16,17; Table 1). The SEARCHPKS program (48)
requires protein sequence input so that preparatory work
to find genes and translate the DNA is necessary. The
MAPSI program (17) works well with genome length
DNA sequences, but the gene finder is not effective for
high G+C DNA of typical cluster length (approx. 100
kb). The SEARCHPKS and MAPSI programs are reason-
ably effective in recognising AT-specificity; this probably
reflects the fact that AT specificity correlates well with
phylogenetic trees (52) so that, in addition to critical
functional amino acids, there are other amino acids that
differ for evolutionary reasons. However, they do not
attempt to predict the hydroxyl or methyl group stereo-
chemistries that are determined by the KR domain. They
also do not predict inactive reduction domains. It is
likely that the use of BLAST (15) searches will not be
capable of recognising such subtle properties of do-
mains. In ClustScan the use of HMMER (23) profiles and
amino acid fingerprints has overcome these problems.
Any analysis program will encounter problems with 'un-
usual' clusters. The ability to edit automatic predictions
and override them is therefore important. The SEARCH-
PKS and MAPSI programs do not allow this. A further
restriction of these two programs is that they cannot
output the results of analyses in a standard form such as
an annotation file (GenBank or EMBL format) or the
results of chemical structure predictions in a format such
as SMILES (31).
Conclusions
ClustScan is an integrated suite of computer pro-
grams that takes a 'top down' approach to annotation. It
makes it possible to analyse the large amounts of data
produced by sequencing projects (genome and meta-
genome data sets) and produce good predictions of the
chemical products allowing identification of interesting
clusters. Without such a tool, it is not practicable to carry
out sufficiently detailed analyses of the mass of data
already available today. Rapid progress in sequencing
technology makes the use of ClustScan and CSDB even
more important. For example, even using the conserva-
tive assumptions that an actinomycete with a large
genome (e.g. Streptomyces species) contains on average
20 TMS gene clusters with unknown biosynthetic prod-
ucts and that 1000 sequenced genomes will be available
in the near future, the identification of 20 000 new gene
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Table 1. The comparison of the ClustScan, SEARCHPKS and MAPSI systems
Features ClustScan SEARCHPKS MAPSI
DNA input Yes Only protein Yesa
Recognises AT specificity Yes Yes Yes
Recognises KR stereochemistry Yes No No
Recognises inactive KR domains Yes No No
Recognises inactive DH domains Yes No No
Recognises inactive ER domains Yes No No
Editing of predictions Yes No No
Exports annotation file Yes No No
Predicts chemical structure Yes No Yesb
Exports chemical structure in standard format Yes No No
aneeds long DNA sequences (>200 kb for high G+C content) for accurate gene identification
blimited structural prediction without editing facilities
cluster DNA sequences can be expected. At present,
most of the clusters revealed by genome projects (e.g. S.
avermitilis) are novel, so it is likely that most of these
new clusters will correspond to novel chemical entities.
The CompGen program suite has also been developed. It
will allow scientists to search our propriety custom data-
base rCSDB of entirely novel chemical structures gene-
rated by in silico homologous recombination and to test
these structures for potential biological activity using com-
puter-aided drug design technology. Pairwise recombi-
nation between 1000 TMS gene clusters could generate
1 000 000 new recombinant gene clusters potentially pro-
ducing novel chemical entities. Most important of all,
when such a product looks promising in silico, a 'design-
er bug' can be created in the laboratory to produce it.
Addendum in Proof
Since sending to press, two additional tools that help
the analysis of new gene clusters CLUSEAN (53) and
NP.searcher (54) have been published but not compared
with the performance of ClustScan (19).
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